glp-1 and gip/glp-1 medications New England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity Indications for GLP-1/GIP RA Summary

Peer-Reviewed Research Advocacy and Clinical Organizations Clinical and News Sources

Mojsov acknowledged the support from Diabetes Action in her Distinguished Medical Science Award acceptance speech and noted that the small grant helped supplement her NIH funding and allowed her to expand her research on GLP-1

Factor meals are shipped fresh and can be heated in minutes, making them convenient for busy or low-energy days

Endothelial dysfunction is a significant component of HFpEF pathophysiology, and glucagon-like peptide-1 receptor (GLP-1R) agonists have shown potential benefits in improving endothelial function

Various factors, such as financial problems, adverse drug reactions, memory issues, and the complexity of diet have been identified as possible mediators of poor adherence to medications in patients with diabetes [138]

[DOI] [PubMed] [Google Scholar] 73.Musso G., Gambino R., Pacini G., De Michieli F., Cassader M